Key result
Schizophrenia was not independently associated with diabetes after adjusting for sociodemographic variables, despite a higher unadjusted prevalence.
Why the study?
Do individuals with schizophrenia have a higher prevalence of cardiovascular risk factors, cardiovascular disease, and health care use compared to those without schizophrenia?
Cross-Sectional (n=120,443)
Do individuals with schizophrenia have a higher prevalence of cardiovascular risk factors, cardiovascular disease, and health care use compared to those without schizophrenia?
Individuals with schizophrenia have higher crude rates of obesity and diabetes, and are more frequently hospitalized, but access primary care at similar rates to the general population, providing opportunities for cardiovascular risk management.
Answers are grounded in this paper and cite their sources.
Higher unadjusted obesity/diabetes rates but equivalent primary care access in schizophrenia; leaves open causality and targeted intervention effects.
PURPOSE: To compare the prevalence of cardiovascular risk factors (CV-RF) and disease (CV-D) and health care use in people with and without schizophrenia. SUBJECTS/MATERIALS AND METHODS: Data from the Canadian Community Health Survey (CCHS), cycle 3.1, were used. Prevalence of CV-RF, CV-D, and health care use were compared in those with and without schizophrenia using logistic regression analysis. Sampling weights and bootstrap variance estimates were used to account for survey design. RESULTS: A total of 399 (0.3%) people with schizophrenia were identified and compared to 120,044 (97.7%) people without. Individuals with schizophrenia were significantly more likely to be obese (34.8% vs. 15.6%) and report diabetes (11.9% vs. 5.3%). After accounting for sociodemographic variables, schizophrenia was not independently associated with diabetes (adjusted odds ratio [aOR]: 0.86; 0.49-1.51). Individuals with schizophrenia were more likely to be hospitalized (21.9% vs. 8.0%; aOR: 2.37; 95% CI: 1.51-3.74) but no more likely to visit their physician (86.7% vs. 85.7%; aOR: 1.23; 95% CI: 0.65-2.35). DISCUSSION/CONCLUSION: Our findings suggest that people with schizophrenia access the primary health care system at least as frequently as someone without schizophrenia, and the opportunity for management of modifiable CV-RF exists in this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Bresee et al. (2010) conducted a cross-sectional in Schizophrenia (n=120,443). Schizophrenia vs. No schizophrenia was evaluated on Diabetes (aOR 0.86, 95% CI 0.49-1.51). Schizophrenia was not independently associated with diabetes after adjusting for sociodemographic variables, despite a higher unadjusted prevalence.
Synapse has enriched 10 related papers. Consider them for comparative context: